154 related articles for article (PubMed ID: 28450405)
1. Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms.
Patel D; Thompson MD; Manna SK; Krausz KW; Zhang L; Nilubol N; Gonzalez FJ; Kebebew E
Clin Cancer Res; 2017 Sep; 23(17):5302-5310. PubMed ID: 28450405
[No Abstract] [Full Text] [Related]
2. Noninvasive urinary metabolomic profiling identifies diagnostic and prognostic markers in lung cancer.
Mathé EA; Patterson AD; Haznadar M; Manna SK; Krausz KW; Bowman ED; Shields PG; Idle JR; Smith PB; Anami K; Kazandjian DG; Hatzakis E; Gonzalez FJ; Harris CC
Cancer Res; 2014 Jun; 74(12):3259-70. PubMed ID: 24736543
[TBL] [Abstract][Full Text] [Related]
3. Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study.
Bancos I; Taylor AE; Chortis V; Sitch AJ; Jenkinson C; Davidge-Pitts CJ; Lang K; Tsagarakis S; Macech M; Riester A; Deutschbein T; Pupovac ID; Kienitz T; Prete A; Papathomas TG; Gilligan LC; Bancos C; Reimondo G; Haissaguerre M; Marina L; Grytaas MA; Sajwani A; Langton K; Ivison HE; Shackleton CHL; Erickson D; Asia M; Palimeri S; Kondracka A; Spyroglou A; Ronchi CL; Simunov B; Delivanis DA; Sutcliffe RP; Tsirou I; Bednarczuk T; Reincke M; Burger-Stritt S; Feelders RA; Canu L; Haak HR; Eisenhofer G; Dennedy MC; Ueland GA; Ivovic M; Tabarin A; Terzolo M; Quinkler M; Kastelan D; Fassnacht M; Beuschlein F; Ambroziak U; Vassiliadi DA; O'Reilly MW; Young WF; Biehl M; Deeks JJ; Arlt W;
Lancet Diabetes Endocrinol; 2020 Sep; 8(9):773-781. PubMed ID: 32711725
[TBL] [Abstract][Full Text] [Related]
4. Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors.
Arlt W; Biehl M; Taylor AE; Hahner S; Libé R; Hughes BA; Schneider P; Smith DJ; Stiekema H; Krone N; Porfiri E; Opocher G; Bertherat J; Mantero F; Allolio B; Terzolo M; Nightingale P; Shackleton CH; Bertagna X; Fassnacht M; Stewart PM
J Clin Endocrinol Metab; 2011 Dec; 96(12):3775-84. PubMed ID: 21917861
[TBL] [Abstract][Full Text] [Related]
5. Adrenal Imaging Features Predict Malignancy Better than Tumor Size.
Yoo JY; McCoy KL; Carty SE; Stang MT; Armstrong MJ; Howell GM; Bartlett DL; Tublin ME; Yip L
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S721-7. PubMed ID: 26088650
[TBL] [Abstract][Full Text] [Related]
6. Serum inhibin pro-αC is a tumor marker for adrenocortical carcinomas.
Hofland J; Feelders RA; van der Wal R; Kerstens MN; Haak HR; de Herder WW; de Jong FH
Eur J Endocrinol; 2012 Feb; 166(2):281-9. PubMed ID: 22127493
[TBL] [Abstract][Full Text] [Related]
7. How to Differentiate Benign from Malignant Adrenocortical Tumors?
Viëtor CL; Creemers SG; van Kemenade FJ; van Ginhoven TM; Hofland LJ; Feelders RA
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503194
[TBL] [Abstract][Full Text] [Related]
8. Urinary Polyamines as Biomarkers for Ovarian Cancer.
Niemi RJ; Roine AN; Häkkinen MR; Kumpulainen PS; Keinänen TA; Vepsäläinen JJ; Lehtimäki T; Oksala NK; Mäenpää JU
Int J Gynecol Cancer; 2017 Sep; 27(7):1360-1366. PubMed ID: 28604456
[TBL] [Abstract][Full Text] [Related]
9. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors.
Sbiera S; Schmull S; Assie G; Voelker HU; Kraus L; Beyer M; Ragazzon B; Beuschlein F; Willenberg HS; Hahner S; Saeger W; Bertherat J; Allolio B; Fassnacht M
J Clin Endocrinol Metab; 2010 Oct; 95(10):E161-71. PubMed ID: 20660055
[TBL] [Abstract][Full Text] [Related]
10. Urinary steroid profiling by gas chromatography mass spectrometry: Early features of malignancy in patients with adrenal incidentalomas.
Shafigullina ZR; Velikanova LI; Vorokhobina NV; Shustov SB; Lisitsin AA; Malevanaia EV; Buinova MO; Bessonova EA; Kirsanov DO
Steroids; 2018 Jul; 135():31-35. PubMed ID: 29689248
[No Abstract] [Full Text] [Related]
11. The urinary steroid profile in patients diagnosed with adrenal incidentaloma.
Kotłowska A; Maliński E; Sworczak K; Kumirska J; Stepnowski P
Clin Biochem; 2009 Apr; 42(6):448-54. PubMed ID: 19297679
[TBL] [Abstract][Full Text] [Related]
12. CT imaging characteristics of oncocytic adrenal neoplasms (OANs): comparison with adrenocortical carcinomas.
Khan M; Caoili EM; Davenport MS; Poznanski A; Francis IR; Giordano T; Dunnick NR
Abdom Imaging; 2014 Feb; 39(1):86-91. PubMed ID: 24271078
[TBL] [Abstract][Full Text] [Related]
13. Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinomas. Implications for the differential diagnosis of adrenal gland tumors.
Komminoth P; Roth J; Schröder S; Saremaslani P; Heitz PU
Lab Invest; 1995 Apr; 72(4):424-31. PubMed ID: 7723281
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the urinary metabolic variations and the application in bladder cancer biomarker discovery.
Liu X; Cheng X; Liu X; He L; Zhang W; Wang Y; Sun W; Ji Z
Int J Cancer; 2018 Jul; 143(2):408-418. PubMed ID: 29451296
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Value of Urinary Steroid Profiling in the Evaluation of Adrenal Tumors.
Kerkhofs TM; Kerstens MN; Kema IP; Willems TP; Haak HR
Horm Cancer; 2015 Aug; 6(4):168-75. PubMed ID: 25985881
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic importance of 18F-FDG PET/CT parameters and total lesion glycolysis in differentiating between benign and malignant adrenal lesions.
Ciftci E; Turgut B; Cakmakcilar A; Erturk SA
Nucl Med Commun; 2017 Sep; 38(9):788-794. PubMed ID: 28692494
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of a malignant adrenal mass: the role of urinary steroid metabolite profiling.
Bancos I; Arlt W
Curr Opin Endocrinol Diabetes Obes; 2017 Jun; 24(3):200-207. PubMed ID: 28234802
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA Expression Profiling in Adrenal Myelolipoma.
Decmann A; Perge P; Nyíro G; Darvasi O; Likó I; Borka K; Micsik T; Tóth Z; Bancos I; Pezzani R; Iacobone M; Patócs A; Igaz P
J Clin Endocrinol Metab; 2018 Sep; 103(9):3522-3530. PubMed ID: 29982598
[TBL] [Abstract][Full Text] [Related]
19. Creatine riboside is a cancer cell-derived metabolite associated with arginine auxotrophy.
Parker AL; Toulabi L; Oike T; Kanke Y; Patel D; Tada T; Taylor S; Beck JA; Bowman E; Reyzer ML; Butcher D; Kuhn S; Pauly GT; Krausz KW; Gonzalez FJ; Hussain SP; Ambs S; Ryan BM; Wang XW; Harris CC
J Clin Invest; 2022 Jul; 132(14):. PubMed ID: 35838048
[TBL] [Abstract][Full Text] [Related]
20. Adrenal masses: characterization with in vivo proton MR spectroscopy--initial experience.
Faria JF; Goldman SM; Szejnfeld J; Melo H; Kater C; Kenney P; Huayllas MP; Demarchi G; Francisco VV; Andreoni C; Srougi M; Ortiz V; Abdalla N
Radiology; 2007 Dec; 245(3):788-97. PubMed ID: 18024453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
